Back
Day Range
$25.29
$26.12
52-Week Range
$14.59
$44.28
Volume
202,945
50D / 200D Avg
$33.34
/
$27.63
Prev Close
$25.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -31.7 | 0.4 |
| P/B | 1.6 | 2.9 |
| ROE % | -5.2 | 3.8 |
| Net Margin % | -7.0 | 3.9 |
| Rev Growth 5Y % | 38.3 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$49.80
+93.4%
Low: $47.00
High: $52.00
Forward EPS
-$1.18
Est. Revenue
350 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.02
$1.01 – $1.03
|
510 M | 1 |
| FY2029 |
$0.57
$0.56 – $0.57
|
470 M | 1 |
| FY2028 |
-$0.03
-$0.36 – $0.31
|
430 M | 5 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 |
Stokes Frank
Chief Financial Officer
|
sell | 6,001 | $27.98 | $167,908 |
| Jan 12, 2026 |
Stokes Frank
Chief Financial Officer
|
grant | 16,248 | — | — |
| Dec 17, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
sell | 14,888 | $39.31 | $585,292 |
| Dec 11, 2025 |
Stokes Frank
Chief Financial Officer
|
sell | 4,496 | $37.45 | $168,375 |
| Dec 10, 2025 |
Stokes Frank
Chief Financial Officer
|
other | 15,098 | — | — |
| Dec 10, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
other | 14,892 | — | — |
| Dec 9, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
other | 36,613 | — | — |
| Dec 9, 2025 |
Stokes Frank
Chief Financial Officer
|
other | 35,766 | — | — |
| Nov 11, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
sell | 18,932 | $35.10 | $664,513 |
| Nov 11, 2025 |
Stokes Frank
Chief Financial Officer
|
sell | 5,388 | $35.08 | $189,011 |
| Oct 31, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
sell | 12,678 | $25.04 | $317,457 |
| Aug 8, 2025 |
Juvenal Tobin W
Chief Commercial Officer
|
other | 25,574 | — | — |
| May 22, 2025 |
Harrison Miles
Director
|
grant | 13,667 | — | — |
| May 22, 2025 |
Caple Kim
Director
|
grant | 13,667 | — | — |
| May 22, 2025 |
Cole G Bradley
Director
|
grant | 13,667 | — | — |
| May 22, 2025 |
Cotton Rodney
Director
|
grant | 13,667 | — | — |
| May 21, 2025 |
Harrison Miles
Director
|
other | 17,346 | — | — |
| May 21, 2025 |
Caple Kim
Director
|
other | 17,346 | — | — |
| May 21, 2025 |
Cole G Bradley
Director
|
other | 17,346 | — | — |
| May 21, 2025 |
Cotton Rodney
Director
|
other | 17,346 | — | — |
Key Takeaways
Revenue grew 38.30% annually over 5 years — strong growth
Earnings declined -232.41% over the past year
Debt/Equity of 0.08 — conservative balance sheet
Generating 28.33M in free cash flow
PEG of 0.21 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 34.64%
Growth
Revenue Growth (5Y)
38.30%
Revenue (1Y)3.66%
Earnings (1Y)-232.41%
FCF Growth (3Y)N/A
Quality
Return on Equity
-5.21%
ROIC-6.32%
Net Margin-7.02%
Op. Margin-12.44%
Safety
Debt / Equity
0.08
Current Ratio5.26
Interest Coverage-497.79
Valuation
P/E Ratio
-31.69
P/B Ratio1.63
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.66% | Revenue Growth (3Y) | 25.15% |
| Earnings Growth (1Y) | -232.41% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38.30% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 344.23M | Net Income (TTM) | -24.16M |
| ROE | -5.21% | ROA | -4.18% |
| Gross Margin | 68.66% | Operating Margin | -12.44% |
| Net Margin | -7.02% | Free Cash Flow (TTM) | 28.33M |
| ROIC | -6.32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.08 | Current Ratio | 5.26 |
| Interest Coverage | -497.79 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -31.69 | P/B Ratio | 1.63 |
| P/S Ratio | 2.22 | PEG Ratio | 0.21 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 765.58M | Enterprise Value | 685.76M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 344.23M | 332.07M | 219.79M | 137.04M | 94.09M |
| Net Income | -24.16M | 18.25M | -57.47M | -67.14M | -31.29M |
| EPS (Diluted) | -0.83 | 0.62 | -2.14 | -2.58 | -1.24 |
| Gross Profit | 236.35M | 271.86M | 174.81M | 105.03M | 78.26M |
| Operating Income | -42.81M | 8.67M | -67.98M | -72.86M | -40.08M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 578.56M | 531.24M | 453.34M | 447.33M | 462.57M |
| Total Liabilities | 107.68M | 75.40M | 62.07M | 48.18M | 50.83M |
| Shareholders' Equity | 470.87M | 455.84M | 391.27M | 399.15M | 411.74M |
| Total Debt | 36.91M | 26.34M | 15.34M | 13.40M | 8.20M |
| Cash & Equivalents | 116.73M | 119.71M | 98.84M | 122.95M | 329.63M |
| Current Assets | 361.10M | 360.15M | 295.64M | 292.29M | 353.74M |
| Current Liabilities | 68.68M | 49.39M | 47.67M | 36.13M | 24.89M |